Advanced topical drug delivery system for the management of vaginal candidiasis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Vaginal candidiasis or vulvovaginal candidiasis (VC) is a common mucosal infection of vagina, mainly caused by Candida species. The major symptoms of VC are dyspareunia, pruritis, itching, soreness, vagina as well as vulvar erythema and edema. Most common risk factors that lead to the imbalance in the vaginal micro biota are the use of antibiotics, pregnancy, diabetes mellitus, immuno suppression as in AIDS or HIV patients, frequent sexual intercourse, spermicide and intra-uterine devices and vaginal douching. Various anti-fungal drugs are available for effective treatment of VC. Different conventional vaginal formulations (creams, gels, suppositories, powder, ointment, etc.) for VC are available today but have limited efficacy because of lesser residence time on vaginal epithelium due to self-cleansing action of vagina. So to overcome this problem, an extended and intimate contact with vaginal mucosa is desired; which can be accomplished by utilizing mucoadhesive polymers. Mucoadhesive polymers have an excellent binding capacity to mucosal tissues for considerable period of time. This unique property of these polymers significantly enhances retention time of different formulations on mucosal tissues. Currently, various novel formulations such as liposomes, nano- and microparticles, micro-emulsions, bio-adhesive gel and tablets are used to control and treat VC. In this review, we focused on current status of vaginal candidiasis, conventional and nanotechnology inspired formulation approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033114 · Cited by 487
A novel glyco-conjugate vaccine against fungal pathogens
Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050749 · Cited by 442
Candida albicans Als3, a multifunctional adhesin and invasin
Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354
Why consider vaginal drug administration?
Alexander, N. J., Baker, E., Kaptein, M., Karck, U., Miller, L., & Zampaglione, E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.025 · Cited by 269
Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, Jr. (2006) · The Journal of Infectious Diseases · doi:10.1086/504691 · Cited by 180 · cited 3×
“Latter on they formulated another vaccine of recombinant N-teminus of Als 3p (rAls 3p) against disseminated and mucosal Candidiasis.”
BackgroundInfluentialThreonine-Rich Repeats Increase Fibronectin Binding in the Candidaalbicans Adhesin Als5p
Rauceo, J. M., De Armond, R., Otoo, H., Kahn, P. C., Klotz, S. A., Gaur, N. K., & Lipke, P. N. (2006) · Eukaryotic Cell · doi:10.1128/ec.00120-06 · Cited by 115 · cited 1×
“N terminus of ALS protein is involved in ligand binding (Loza et al., 2004; Rauceo et al., 2006; Liu & Filler, 2011).”
BackgroundIbrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83 · cited 1×
“The vaccine enhances cell-mediated immunity rather than humoral and improves survival of mice during candidiasis (Ibrahim et al., 2005).”
BackgroundFunctional analysis of the Candida albicans ALS1 gene product
Loza, L., Fu, Y., Ibrahim, A. S., Sheppard, D. C., Filler, S. G., & Edwards, J. E. (2004) · Yeast · doi:10.1002/yea.1111 · Cited by 78 · cited 1×
“…provide moisture Solubilize solid dosage formulations in vagina Volume and composition of vaginal fluid varies with age, infection, sexual arousal (Masters & Johnson, 1966) pH Range of 3.5–4.5 (average 4.2) Lactobacillus sp. produces lactic acid from glycogen, which helps in maintaining healthy…”
BackgroundInfluential
Cited by
Recent Developments in Antimicrobial Polymers: A Review
Santos, M., Fonseca, A., Mendonça, P., Branco, R., Serra, A., Morais, P., & Coelho, J. (2016) · Materials · doi:10.3390/ma9070599 · Cited by 210
Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients
Rahman, S. A., Abdelmalak, N. S., Badawi, A., Elbayoumy, T., Sabry, N., & El Ramly, A. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1041578 · Cited by 64
“Liposomes have been successfully used to encapsulate lipophilic and hydrophilic compounds (Eroğlu et al., 2014; Johal et al., 2014; Ali et al., 2014; El-badry et al., 2014; Fang et al., 2015).”
Recent developments on using nanomaterials to combat Candida albicans
Li, B., Pan, L., Zhang, H., Xie, L., Wang, X., Shou, J., Qi, Y., & Yan, X. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.813973 · Cited by 43
de Oliveira Neto, A. S., Souza, I. L. A., Amorim, M. E. S., de Freitas Souza, T., Rocha, V. N., do Couto, R. O., Fabri, R. L., & de Freitas Araújo, M. G. (2021) · Medical Mycology · doi:10.1093/mmy/myaa071 · Cited by 22
Lajarin-Reinares, M., Naveira-Souto, I., Mallandrich, M., Suñer-Carbó, J., Llagostera Casas, M., Calvo, M. A., & Fernandez-Campos, F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051436 · Cited by 2
“Vaginal candidiasis (VC), often referred to as vulvovaginal candidiasis, is mainly caused by the Candida species and is the second most prevalent infection of the vaginal mucosa after bacterial vaginosis [1].”
Background
Metadata
- Authors
- Johal, H. S., Garg, T., Rath, G., & Goyal, A. K.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2014-06-24
- Volume
- 23
- Issue
- 2
- Pages
- 550-563
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2040810538
- Cited by
- 155
- References
- 9
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced topical drug delivery system for the management of vaginal candidiasis. https://app.cochat.ai/papers/10.3109/10717544.2014.928760
- The paper
- Johal, H. S., Garg, T., Rath, G., & Goyal, A. K. (2016). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Delivery. https://doi.org/10.3109/10717544.2014.928760
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.